Protocol group
medication-imatinib
3 protocols · 4 outcomes with evidence
Protocols (3)
Outcomes & scoring
biomarker-hematology-hepatosplenomegaly-reduction1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| medication-imatinib-mesylate-daily | +20 | 40 | 14 |
oncology-overall-response-rate-percent1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| medication-imatinib-generic | +15 | 25 | 11 |
skin-and-constitutional-symptom-reduction1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| medication-imatinib-mesylate-daily | +20 | 40 | 14 |
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| medication-imatinib-tyrosine-kinase-inhibitor-for-well-differentiated-systemic-mastocytosis | +85 | 45 | 1 |
Path: medication › imatinib